SG3 Management’s Repligen RGEN Stock Holding History

SG3 Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$2.21M	–	1186
2020 Q3	$2.21M	Buy	+15,000	New	+$2.14M	0.08%	254

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

SG3 Management's RGEN Position: Q4 2020 in Review

SG3 Management sold out of Repligen (RGEN) in Q4 2020, closing a stake of 20,000 shares — an estimated $2.95M sold.

SG3 Management first reported a position in RGEN in Q3 2020 and held it in 1 quarter. The position peaked at $2.95M in Q3 2020. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

SG3 Management reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
SG3 Management sold 20,000 Repligen shares in Q4 2020, an estimated $2.95M.
SG3 Management first reported a position in Repligen in Q3 2020 and held it in 1 quarter.
SG3 Management's Repligen position peaked at $2.95M in Q3 2020.
449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on SG3 Management's 13F filing for Q4 2020, filed 16 Feb 2021.